A Comprehensive Review on Monkeypox Viral Disease with Potential Diagnostics and Therapeutic Options

Ali A. Rabaan, Seham A. Al-Shwaikh, Wadha A. Alfouzan, Ali M. Al-Bahar, Mohammed Garout, Muhammad A. Halwani, Hawra Albayat, Norah B. Almutairi, Mohammed Alsaeed, Jeehan H. Alestad, Maha A. Al-Mozaini, Tala M.Al Ashgar, Sultan Alotaibi, Abdulmonem A. Abuzaid, Yahya Aldawood, Abdulmonem A. Alsaleh, Hani M. Al-Afghani, Jaffar A. Altowaileb, Abeer N. Alshukairi, Kovy Arteaga-LiviasKirnpal Kaur Banga Singh, Mohd Imran

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

1 Cita (Scopus)


The purpose of this review is to give an up-to-date, thorough, and timely overview of monkeypox (Mpox), a severe infectious viral disease. Furthermore, this review provides an up-to-date treatment option for Mpox. The monkeypox virus (MPXV) has remained the most virulent poxvirus for humans since the elimination of smallpox approximately 41 years ago, with distribution mainly in central and west Africa. Mpox in humans is a zoonotically transferred disease that results in symptoms like those of smallpox. It had spread throughout west and central Africa when it was first diagnosed in the Republic of Congo in 1970. Mpox has become a major threat to global health security, necessitating a quick response by virologists, veterinarians, public health professionals, doctors, and researchers to create high-efficiency diagnostic tests, vaccinations, antivirals, and other infection control techniques. The emergence of epidemics outside of Africa emphasizes the disease’s global significance. A better understanding of Mpox’s dynamic epidemiology may be attained by increased surveillance and identification of cases.

Idioma originalInglés
Número de artículo1826
EstadoPublicada - jul. 2023


Profundice en los temas de investigación de 'A Comprehensive Review on Monkeypox Viral Disease with Potential Diagnostics and Therapeutic Options'. En conjunto forman una huella única.

Citar esto